Key Takeaways:
- Curaleaf launches JAMS Remix, a new line of fast-acting cannabis jellies in Arizona, with expansion to New York and Massachusetts in September.
- JAMS Remix includes Shineapple for morning, Sootheberry for mid-day, and Lullaberry for nighttime use.
- The jellies are designed with targeted cannabinoid ratios and functional ingredients.
Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) has launched JAMS Remix, a new line of cannabis-infused jellies that offer fast-acting effects with precise cannabinoid ratios.
ALSO READ: Curaleaf’s Select Brand Enhances Product Line with Introduction of Select Stiq
As per a news release the product line debuted on August 30, 2024, in Arizona, with New York and Massachusetts to follow in late September.
The release added that additional markets, including Connecticut, Maryland, New Jersey, Illinois, and Utah, are expected to launch pending regulatory approval.
The release stated that JAMS Remix offers three formulations:
- Shineapple: Pineapple strawberry-flavored jelly with 10 mg THC, 5 mg THCV, 5 mg CBG, and B12 vitamins for energy.
- Sootheberry: Raspberry pomegranate-flavored jelly with 10 mg THC, 5 mg CBD, 5 mg CBG, and L-Theanine for relaxation.
- Lullaberry: Blackberry-flavored jelly with 10 mg THC, 5 mg CBN, 5 mg CBD, and melatonin for sleep support.
The release highlighted that these jellies are designed to meet specific consumer needs at different times of the day.
ALSO READ: Curaleaf Introduces Stir, a New THC Beverage Mix, Expanding Zero Proof Brand
JAMS Remix is the latest addition to the JAMS brand, which launched in 2023. The brand includes various cannabis-infused edibles crafted to meet diverse consumer preferences.
Learn more in this release.